Antithrombin activity during the period of percutaneous coronary revascularization

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.

Jeffrey I. Weitz, Monika Hudoba, David Massel et al. · Journal of Clinical Investigation · 1990 · 1.1K citations · Full text

Medicine, Cardiology, Pharmacology +16

Guidelines for percutaneous transluminal coronary angioplasty

Thomas J. Ryan · Journal of the American College of Cardiology · 1988 · 1K citations

Medicine, Cardiology, Surgery +12

Treatment with Bivalirudin (Hirulog) as Compared with Heparin during Coronary Angioplasty for Unstable or Postinfarction Angina

John A. Bittl, John Strony, Jeffrey Brinker et al. · New England Journal of Medicine · 1995 · 496 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Reactivation of Unstable Angina after the Discontinuation of Heparin

Pierre Théroux, David D. Waters, Jules Y.T. Lam et al. · New England Journal of Medicine · 1992 · 465 citations · Full text

Medicine, Cardiology, Pharmacotherapy +12

Inherited thrombophilia: pathogenesis, clinical syndromes, and management [see comments]

Valerio De Stefano, Guido Finazzi, PM Mannucci · Blood · 1996 · 435 citations · Full text

Medicine, Genetics, Hematology +12